Answers are grounded in this paper and cite their sources.
We describe a patient with invasive pulmonary aspergillosis on extracorporeal membrane oxygenation therapy in which therapeutic drug monitoring and individualization of therapy by measuring voriconazole plasma concentrations were performed.
No takes yet. Share an insight, caveat, or question.
Brüggemann et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: